CRYOPORT, INC. Increase Decrease In Operating Lease Liability
CRYOPORT, INC. (CYRX) reported Increase Decrease In Operating Lease Liability of -$2.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- CRYOPORT, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$1.07M.
- CRYOPORT, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$1.21M.
- CRYOPORT, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$1.07M.
- CRYOPORT, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$1.03M.
- CRYOPORT, INC. increase decrease in operating lease liability for fiscal 2025 was -$5.04M.
- CRYOPORT, INC. increase decrease in operating lease liability for fiscal 2024 was -$5.34M.
- CRYOPORT, INC. increase decrease in operating lease liability for fiscal 2023 was -$4.59M.
- CRYOPORT, INC. increase decrease in operating lease liability for fiscal 2022 was -$3.08M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.28M 10-Q · filed 2026-08-06 | -$3.35M derived: sum of 3 quarters · filed 2026-08-06 | -$4.38M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.21M 10-Q · filed 2026-05-05 | -$2.28M derived: sum of 2 quarters · filed 2026-05-05 | -$3.31M derived: sum of 3 quarters · filed 2026-05-05 | -$4.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$2.10M derived: sum of 2 quarters · filed 2026-03-05 | -$3.75M derived: sum of 3 quarters · filed 2026-08-06 | -$5.04M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.68M derived: sum of 2 quarters · filed 2026-08-06 | -$3.97M 10-Q · filed 2025-11-06 | -$5.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.94M 10-Q · filed 2026-08-06 | -$3.99M derived: sum of 3 quarters · filed 2026-08-06 | -$5.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.29M 10-Q · filed 2026-05-05 | -$2.35M derived: sum of 2 quarters · filed 2026-05-05 | -$3.87M derived: sum of 3 quarters · filed 2026-05-05 | -$5.33M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$2.59M derived: sum of 2 quarters · filed 2026-03-05 | -$4.04M derived: sum of 3 quarters · filed 2026-03-05 | -$5.34M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.98M derived: sum of 2 quarters · filed 2025-11-06 | -$4.28M 10-Q · filed 2025-11-06 | -$5.87M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.75M 10-Q · filed 2025-08-12 | -$4.34M derived: sum of 3 quarters · filed 2026-03-05 | -$5.25M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | -$1.30M 10-Q · filed 2025-05-08 | -$2.89M derived: sum of 2 quarters · filed 2026-03-05 | -$3.79M derived: sum of 3 quarters · filed 2026-03-05 | -$4.89M derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$2.49M derived: sum of 2 quarters · filed 2026-03-05 | -$3.59M derived: sum of 3 quarters · filed 2026-03-05 | -$4.59M 10-K · filed 2026-03-05 |
| 2023-09-30 | -$907.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.00M derived: sum of 2 quarters · filed 2024-11-07 | -$3.01M 10-Q · filed 2024-11-07 | -$3.71M derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.10M 10-Q · filed 2024-08-08 | -$2.81M derived: sum of 3 quarters · filed 2025-03-07 | -$3.37M derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-03-31 | -$1.00M 10-Q · filed 2024-05-08 | -$1.71M derived: sum of 2 quarters · filed 2025-03-07 | -$2.27M derived: sum of 3 quarters · filed 2025-03-07 | -$3.19M derived: sum of 4 quarters · filed 2025-03-07 |
| 2022-12-31 | -$704.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$1.27M derived: sum of 2 quarters · filed 2025-03-07 | -$2.19M derived: sum of 3 quarters · filed 2025-03-07 | -$3.08M 10-K · filed 2025-03-07 |
| 2022-09-30 | -$565.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.48M derived: sum of 2 quarters · filed 2023-11-09 | -$2.37M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$916.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.81M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$891.00K 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$2.81M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |